Why Canopy Growth (TSX:WEED) Stock Fell 17% in May

Canopy Growth Corp’s (TSX:WEED)(NYSE:CGC) potential multi-billion acquisition of New York-based Acreage Holdings has drawn a lot of criticism.

| More on:
edit Jars of marijuana

Image source: Getty Images

Canopy Growth (TSX:WEED)(NYSE:WEED) lost 17% of its value in May.

There are two reasons investors fled its stock in the past month. One of them is a sector-wide problem and the other is specific to Canopy itself. Neither will likely be permanently scarring, but there could be further declines in June. Here’s why.

The first issue with investors is its announced multi-billion potential deal to buy New York-based Acreage Holdings for US$3.4 billion. Although there is a lot of support for the tie-up of the two companies, the deal will only happen if cannabis is legalized federally in the U.S. Until then, Acreage gets $300 million in a cash downpayment, and the two companies will share intelligence with each other as they continue to press Washington to move faster on legalization.

As I said, not everyone is happy about the deal. Fool contributor David Jagielski recently discussed the possibility that the deal could fall through.

Mercato Capital Management, which owns 2.7% of Acreage’s stock, believes that the company’s value, once cannabis is legalized, would be worth a lot more than the US$3.4 billion Canopy Growth is currently offering. Investors who hold Canopy Growth stock understand that CEO Bruce Linton’s arrangement is a smart way to get a foot in the door of the U.S. market without running afoul of U.S. laws and regulations.

However, if the June 19 vote fails to get enough shareholder support, Canopy Growth will be back at square one with other big players a little wiser to the company’s Trojan Horse solution. That could have consequences on the stock for some time after the vote is held.

The second thing weighing on Canopy Growth’s stock in May is the underwhelming earnings results of some cannabis producers combined with the fact that three of Canada’s largest pot producers — Aurora Cannabis, Tilray, and Cronos Group — all had good quarterly results on the top line.

Investors have no idea what Canopy Growth’s results will look like when it reports earnings June 20. Until then, WEED shares should remain in a downward trend.     

Up almost 49% in 2019, investors still ought to be happy with its year-to-date performance. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Will Ashworth has no position in any stocks mentioned.  

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »